KELLEHER FINANCIAL ADVISORS

Position in NKTR — Nektar Therapeutics

CIK 1507971 NEW YORK, NY

Position in NKTR

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$14,390

New position

Shares Held

200

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Healthcare · as of Mar 31, 2026

KELLEHER FINANCIAL ADVISORS holds $324,622 across 5 Biotechnology names. NKTR ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LENZ	LENZ Therapeutics, Inc.	17,023	$155,760
2	MRNA	Moderna, Inc.	1,335	$67,818
3	VRTX	Vertex Pharmaceuticals Inc / Ma	100	$44,654
4	NWBO	Northwest Biotherapeutics Inc	200,000	$42,000
5	NKTR	Nektar Therapeutics This page	200	$14,390

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,390	200	—	Shares	Sole	2026-05-08
No filing history on record for this holder in this stock.